| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.32 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |